Oramed Pharmaceuticals Inc.
09/17/2026 | Press release | Distributed by Public on 09/17/2026 13:38
Proxy Results (Form 8-K)
Item 5.07. Submission of Matters to a Vote of Security Holders.
On September 15, 2026, the Company held its 2026 Annual Meeting of Stockholders. The final voting results at the 2026 Annual Meeting of Stockholders (the "Annual Meeting") are set forth below.
Proposal No. 1 - Re-election of Directors.
The stockholders re-elected the following directors of the Company to hold office until the next annual meeting of stockholders and until their respective successors shall be elected and qualified or until their earlier resignation or removal. The votes were as follows:
| Director Name | For | Against | Abstain |
Broker Non-Votes |
||||
| Dr. Daniel Aghion | 12,662,432 | 4,769,203 | 20,234 | 7,538,073 | ||||
| Dr. Miriam Kidron | 13,672,468 | 3,756,991 | 22,410 | 7,538,073 | ||||
| Nadav Kidron | 13,702,335 | 3,729,485 | 20,049 | 7,538,073 | ||||
| Dr. Arie Mayer | 11,784,397 | 5,648,636 | 18,836 | 7,538,073 | ||||
| Yehuda Reznick | 13,687,270 | 3,735,295 | 29,304 | 7,538,073 | ||||
| Benjamin Shapiro | 11,567,510 | 5,859,953 | 24,406 | 7,538,073 |
Oramed Pharmaceuticals Inc. published this content on September 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on September 17, 2026 at 19:38 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]